Arcosa, Inc. (ACA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ACA SEC filings page.
Arcosa, Inc. (ACA) reported $2.9B in revenue over the twelve months to Jun 30, 2026, up 16.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Arcosa’s 2025 rebound came from wider margins and easing leverage, but capital spending still absorbed much of operating cash.
Net income more than doubled in FY2025, yet free cash flow fell to$176M from$312M in FY2024; this gap shows the earnings rebound did not translate one-for-one into cash after reinvestment.
The 2024 balance-sheet expansion left Arcosa with
Gross margin widened to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Arcosa, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Arcosa, Inc. has an operating margin of 11.9%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 68/100, reflecting efficient cost management and pricing power. This is up from 7.7% the prior year.
Arcosa, Inc.'s revenue grew 12.2% year-over-year to $2.9B, a solid pace of expansion. This earns a growth score of 69/100.
Arcosa, Inc. has elevated debt relative to equity (D/E of 0.57), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.
Arcosa, Inc.'s current ratio of 2.20 indicates adequate short-term liquidity, earning a score of 64/100. The company can meet its near-term obligations, though with limited headroom.
Arcosa, Inc. has a free cash flow margin of 6.1%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Arcosa, Inc.'s ROE of 7.9% shows moderate profitability relative to equity, earning a score of 55/100. This is up from 3.9% the prior year.
Arcosa, Inc. scores 3.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($7.2B) relative to total liabilities ($2.3B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Arcosa, Inc. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Arcosa, Inc. generates $1.64 in operating cash flow ($341.1M OCF vs $208.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Arcosa, Inc. earns $3.14 in operating income for every $1 of interest expense ($341.9M vs $108.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Arcosa, Inc. generated $658.7M in revenue in Q2 2026. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 15.2%.
Arcosa, Inc.'s EBITDA was $142.3M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is up 41.5%.
Arcosa, Inc. reported $328.5M in net income in Q2 2026. This represents an increase of 450.3% from the same quarter a year earlier. Against the prior quarter it is up 769.0%.
Arcosa, Inc. earned $6.67 per diluted share (EPS) in Q2 2026. This represents an increase of 446.7% from the same quarter a year earlier. Against the prior quarter it is up 766.2%.
Cash & Balance Sheet
Arcosa, Inc. recorded an outflow of $70.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 309.6% from the same quarter a year earlier. Against the prior quarter it is down 346.5%.
Arcosa, Inc. held $432.1M in cash against $1.4B in long-term debt as of Q2 2026.
Arcosa, Inc. paid $0.05 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Arcosa, Inc.'s gross margin was 23.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.
Arcosa, Inc.'s operating margin was 12.8% in Q2 2026, reflecting core business profitability. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.6 percentage points.
Arcosa, Inc.'s net profit margin was 49.9% in Q2 2026, showing the share of revenue converted to profit. This is up 40.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 43.3 percentage points.
Arcosa, Inc.'s ROE was 11.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.6 percentage points.
Capital Allocation
Arcosa, Inc. repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.
Arcosa, Inc. invested $58.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 111.5% from the same quarter a year earlier. Against the prior quarter it is up 35.2%.
Not reported for Q2 2026.
ACA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $658.7M+1.7% | $571.7M+4.4% | $890.5M+33.7% | $797.8M+24.6% | $647.5M-2.6% | $547.6M-8.5% | $666.2M+14.4% | $640.4M+8.2% |
| Cost of Revenue | $503.0M+1.2% | $450.8M+2.5% | $693.4M+29.1% | $605.9M+20.3% | $497.2M-5.6% | $439.7M-9.7% | $537.3M+13.1% | $503.7M+3.9% |
| Gross Profit | $155.7M+3.6% | $120.9M+12.0% | $197.1M+52.9% | $191.9M+40.4% | $150.3M+8.9% | $107.9M-3.3% | $128.9M+20.5% | $136.7M+27.6% |
| SG&A Expenses | $89.1M+27.3% | $75.8M+6.8% | $83.9M-5.7% | $82.2M-0.2% | $70.0M-11.9% | $71.0M+2.7% | $89.0M | $82.4M+34.4% |
| Operating Income | $84.3M+2.8% | $47.1M+14.9% | $106.6M+146.8% | $112.3M+232.2% | $82.0M+22.0% | $41.0M-23.2% | $43.2M+0.9% | $33.8M-30.2% |
| EBITDA | $142.3M+4.5% | $100.6M+8.5% | $167.5M+61.7% | $168.5M+113.3% | $136.2M+19.7% | $92.7M-3.6% | $103.6M+24.1% | $79.0M-11.1% |
| Interest Expense | $23.1M-18.9% | $24.0M-15.2% | $24.9M-29.7% | $27.1M+71.5% | $28.5M+150.0% | $28.3M+241.0% | $35.4M+391.7% | $15.8M+135.8% |
| Income Tax | $11.4M+75.4% | $1.3M-53.6% | $9.5M-47.5% | $14.1M+464.0% | $6.5M-14.5% | $2.8M-65.4% | $18.1M+92.6% | $2.5M-66.7% |
| Net Income | $328.5M+450.3% | $37.8M+60.2% | $52.1M+776.6% | $73.0M+339.8% | $59.7M+30.9% | $23.6M-39.8% | -$7.7M-128.4% | $16.6M-53.2% |
| EPS (Basic) | $6.68+447.5% | $0.77+60.4% | $1.06+762.5% | $1.49+338.2% | $1.22+31.2% | $0.48-40.7% | -$0.16-128.6% | $0.34-53.4% |
| EPS (Diluted) | $6.67+446.7% | $0.77+60.4% | $1.06+762.5% | $1.48+335.3% | $1.22+31.2% | $0.48-40.0% | -$0.16-128.6% | $0.34-52.8% |
| Diluted Shares (Avg) | 49M+0.4% | 49M0.0% | N/A | 49M+0.6% | 49M+0.6% | 49M+0.6% | N/A | 49M0.0% |
Not reported in any period shown, so not listed: R&D Expenses.
ACA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.3B+5.8% | $5.0B+1.4% | $5.0B+1.4% | $5.1B+16.0% | $5.0B+31.6% | $4.9B+34.5% | $4.9B+37.4% | $4.4B+24.9% |
| Current Assets | $1.4B+26.3% | $1.1B+12.1% | $1.1B+16.0% | $1.2B-24.8% | $1.1B+12.7% | $1.0B+1.8% | $954.0M+4.6% | $1.6B+63.9% |
| Cash & Equivalents | $432.1M+127.8% | $153.2M-8.8% | $214.6M+14.6% | $220.0M-70.9% | $189.7M+82.9% | $167.9M-4.9% | $187.3M+78.7% | $756.8M+387.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $364.2M-10.5% | $350.0M-4.1% | $335.9M-6.7% | $420.7M+16.7% | $406.8M+0.2% | $365.0M-9.7% | $359.9M-10.4% | $360.4M-0.2% |
| Accounts Receivable | $559.0M+17.2% | $413.9M-3.2% | $412.6M+17.8% | $480.3M+21.2% | $477.0M+7.7% | $427.6M+16.8% | $350.2M-1.9% | $396.4M+1.7% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.3B+0.4% | $1.3B0.0% | $1.3B-2.4% | $1.3B+33.6% | $1.3B+31.3% | $1.3B+36.5% | $1.4B+37.4% | $1.0B+4.4% |
| Total Liabilities | $2.3B-7.4% | $2.3B-5.2% | $2.3B-5.8% | $2.5B+28.4% | $2.5B+79.7% | $2.5B+91.6% | $2.5B+99.6% | $1.9B+63.7% |
| Current Liabilities | $452.3M-14.3% | $489.6M-4.0% | $503.7M-2.4% | $579.7M+34.1% | $527.5M+22.8% | $510.0M+17.3% | $516.0M+19.7% | $432.3M+6.7% |
| Non-Current Liabilities | $1.9B-5.5% | $1.9B-5.6% | $1.8B-6.7% | $1.9B+26.7% | $2.0B+105.1% | $2.0B+129.2% | $2.0B+142.0% | $1.5B+93.8% |
| Long-Term Debt | $1.4B-14.6% | $1.5B-9.7% | $1.5B-9.7% | $1.6B+27.7% | $1.7B+139.1% | $1.7B+178.9% | $1.7B+198.4% | $1.2B+144.9% |
| Total Equity | $3.0B+18.9% | $2.7B+8.1% | $2.6B+8.8% | $2.6B+6.2% | $2.5B+3.9% | $2.5B+3.4% | $2.4B+4.1% | $2.4B+5.1% |
| Retained Earnings | $1.3B+58.2% | $982.7M+27.6% | $947.3M+26.5% | $897.7M+18.3% | $827.2M+11.1% | $770.0M+9.7% | $748.9M+12.6% | $759.0M+18.5% |
ACA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$11.2M-118.3% | $71.9M+10371.4% | $120.0M-51.7% | $160.6M+19.0% | $61.2M+59.8% | -$700K-100.9% | $248.2M+299.0% | $135.0M+207.5% |
| Depreciation & Amortization | $58.0M+7.0% | $53.5M+3.5% | $57.1M-5.5% | $56.2M+24.3% | $54.2M+16.3% | $51.7M+20.8% | $60.4M+48.4% | $45.2M+11.6% |
| Stock-Based Compensation | $6.0M-6.3% | $6.3M-1.6% | N/A | $6.4M+30.6% | $6.4M-13.5% | $6.4M-4.5% | N/A | $4.9M-14.0% |
| Capital Expenditures | $58.8M+111.5% | $43.5M+31.8% | $64.2M+20.5% | $39.6M+15.1% | $27.8M-41.6% | $33.0M-39.3% | $53.3M-9.2% | $34.4M-28.2% |
| Free Cash Flow | -$70.0M-309.6% | $28.4M+184.3% | $55.8M-71.4% | $121.0M+20.3% | $33.4M+459.1% | -$33.7M-229.1% | $194.9M+5468.6% | $100.6M+2615.0% |
| Investing Cash Flow | $378.9M+1822.3% | -$98.3M-762.3% | -$61.4M+95.1% | -$26.6M-183.0% | -$22.0M+88.9% | -$11.4M+73.8% | -$1.3B-715.5% | -$9.4M+79.3% |
| Financing Cash Flow | -$88.8M-410.3% | -$35.0M-379.5% | -$64.0M-114.5% | -$103.7M-119.7% | -$17.4M-120.1% | -$7.3M-121.0% | $440.6M+959.1% | $527.5M+1383.5% |
| Dividends Paid | $2.5M0.0% | $2.4M-4.0% | $2.5M+4.2% | $2.5M+4.2% | $2.5M0.0% | $2.5M+4.2% | $2.4M-4.0% | $2.4M-4.0% |
| Share Buybacks | $0 | $17.5M | N/A | N/A | $0 | $0 | N/A | N/A |
ACA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.6%+0.4pp | 21.1%+1.4pp | 22.1%+2.8pp | 24.1%+2.7pp | 23.2%+2.4pp | 19.7%+1.1pp | 19.4%+1.0pp | 21.3%+3.3pp |
| Operating Margin | 12.8%+0.1pp | 8.2%+0.8pp | 12.0%+5.5pp | 14.1%+8.8pp | 12.7%+2.5pp | 7.5%-1.4pp | 6.5%-0.9pp | 5.3%-2.9pp |
| Net Margin | 49.9%+40.6pp | 6.6%+2.3pp | 5.9%+7.0pp | 9.2%+6.6pp | 9.2%+2.4pp | 4.3%-2.2pp | -1.2%-5.8pp | 2.6%-3.4pp |
| Return on Equity | 11.0%+8.6pp | 1.4%+0.5pp | 2.0%+2.3pp | 2.8%+2.1pp | 2.4%+0.5pp | 1.0%-0.7pp | -0.3%-1.5pp | 0.7%-0.9pp |
| Return on Assets | 6.2%+5.0pp | 0.8%+0.3pp | 1.1%+1.2pp | 1.4%+1.1pp | 1.2%0.0pp | 0.5%-0.6pp | -0.2%-0.9pp | 0.4%-0.6pp |
| Current Ratio | 3.12+1.0x | 2.31+0.3x | 2.20+0.3x | 2.02-1.6x | 2.12-0.2x | 1.98-0.3x | 1.85-0.3x | 3.61+1.3x |
| Debt-to-Equity | 0.48-0.2x | 0.57-0.1x | 0.57-0.1x | 0.61+0.1x | 0.67+0.4x | 0.68+0.4x | 0.69+0.4x | 0.51+0.3x |
| Asset Turnover | 0.120.0x | 0.110.0x | 0.180.0x | 0.160.0x | 0.130.0x | 0.11-0.1x | 0.140.0x | 0.150.0x |
| FCF Margin | -10.6%-15.8pp | 5.0%+11.1pp | 6.3%-23.0pp | 15.2%-0.5pp | 5.2%+6.6pp | -6.2%-10.5pp | 29.3%+28.7pp | 15.7%+16.4pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Arcosa, Inc. ACA | FY2025 | $2.9B | $208.4M | 7.2% | $7.2B | 57/100 |
| Granite Construction Inc. GVA | FY2025 | $4.4B | $193.0M | 4.4% | $4.9B | 51/100 |
| Everus Construction Group, Inc. ECG | FY2025 | $3.7B | $201.8M | 5.4% | $5.6B | 66/100 |
| Primoris Services Corporation PRIM | FY2025 | $7.6B | $274.9M | 3.6% | $3.9B | 63/100 |
| KBR, Inc. KBR | FY2025 | $7.8B | $415.0M | 5.3% | $4.6B | 50/100 |
| IES Holdings, Inc. IESC | FY2025 | $3.4B | $306.0M | 9.1% | $10.7B | 71/100 |
Where Arcosa, Inc. Ranks
Frequently Asked Questions
What is Arcosa, Inc.'s annual revenue?
Arcosa, Inc. (ACA) reported $2.9B in total revenue for fiscal year 2025. This represents a 12.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Arcosa, Inc.'s revenue growing?
Arcosa, Inc. (ACA) revenue grew by 12.2% year-over-year, from $2.6B to $2.9B in fiscal year 2025.
Is Arcosa, Inc. profitable?
Yes, Arcosa, Inc. (ACA) reported a net income of $208.4M in fiscal year 2025, with a net profit margin of 7.2%.
What is Arcosa, Inc.'s EBITDA?
Arcosa, Inc. (ACA) had EBITDA of $564.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Arcosa, Inc. have?
As of fiscal year 2025, Arcosa, Inc. (ACA) had $214.6M in cash and equivalents against $1.5B in long-term debt.
What is Arcosa, Inc.'s gross margin?
Arcosa, Inc. (ACA) had a gross margin of 22.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Arcosa, Inc.'s operating margin?
Arcosa, Inc. (ACA) had an operating margin of 11.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Arcosa, Inc.'s net profit margin?
Arcosa, Inc. (ACA) had a net profit margin of 7.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Arcosa, Inc. pay dividends?
Yes, Arcosa, Inc. (ACA) paid $0.20 per share in dividends during fiscal year 2025.
What is Arcosa, Inc.'s return on equity (ROE)?
Arcosa, Inc. (ACA) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Arcosa, Inc.'s free cash flow?
Arcosa, Inc. (ACA) generated $175.5M in free cash flow during fiscal year 2025. This represents a -43.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Arcosa, Inc.'s operating cash flow?
Arcosa, Inc. (ACA) generated $341.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Arcosa, Inc.'s total assets?
Arcosa, Inc. (ACA) had $5.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Arcosa, Inc.'s capital expenditures?
Arcosa, Inc. (ACA) invested $165.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Arcosa, Inc.'s current ratio?
Arcosa, Inc. (ACA) had a current ratio of 2.20 as of fiscal year 2025, which is generally considered healthy.
What is Arcosa, Inc.'s debt-to-equity ratio?
Arcosa, Inc. (ACA) had a debt-to-equity ratio of 0.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Arcosa, Inc.'s return on assets (ROA)?
Arcosa, Inc. (ACA) had a return on assets of 4.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Arcosa, Inc.'s P/E ratio?
Arcosa, Inc. (ACA) trades at 14.7x earnings, its market capitalization divided by net income of $491.4M net income, trailing 12 months to June 30, 2026. The market capitalization is $7.2B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Arcosa, Inc.'s price-to-sales ratio?
Arcosa, Inc. (ACA) trades at 2.5x sales, its market capitalization divided by revenue of $2.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $7.2B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Arcosa, Inc.'s Altman Z-Score?
Arcosa, Inc. (ACA) has an Altman Z-Score of 3.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Arcosa, Inc.'s Piotroski F-Score?
Arcosa, Inc. (ACA) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Arcosa, Inc.'s earnings high quality?
Arcosa, Inc. (ACA) has an earnings quality ratio of 1.64x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Arcosa, Inc. cover its interest payments?
Arcosa, Inc. (ACA) has an interest coverage ratio of 3.14x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Arcosa, Inc.?
Arcosa, Inc. (ACA) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.